{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:34:53Z","timestamp":1787168093835,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.14283\/jpad.2020.69","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:32:41Z","timestamp":1612398761000},"page":"7-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Margaret","family":"Moline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Thein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bsharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rabbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kemethofer-Waliczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Filippov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dhadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2020.69_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnins.2018.00330","article-title":"Sleep disorders associated with Alzheimer's disease: a perspective","volume":"12","author":"Brzecka","year":"2018","journal-title":"Front Neurosd"},{"key":"10.14283\/jpad.2020.69_bib2","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/emm.2014.121","article-title":"Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease","volume":"47","author":"Musiek","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.14283\/jpad.2020.69_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsmc.2009.01.009","article-title":"Circadian rhythm sleep disorder: irregular sleep wake rhythm type","volume":"4","author":"Zee","year":"2009","journal-title":"Sleep Med Clin"},{"key":"10.14283\/jpad.2020.69_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ncl.2012.08.011","article-title":"Circadian rhythm sleep disorders","volume":"30","author":"Zhu","year":"2012","journal-title":"Neurol Clin"},{"key":"10.14283\/jpad.2020.69_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gerinurse.2017.06.003","article-title":"Impact of Alzheimer disease patients' sleep disturbances on their caregivers","volume":"39","author":"Gehrman","year":"2018","journal-title":"Geriatr Nurs"},{"key":"10.14283\/jpad.2020.69_bib6","first-page":"1199","volume":"11","author":"Auger","year":"2015","journal-title":"An update for 2015: an American Academy of Sleep Medicine clinical practice guideline"},{"key":"10.14283\/jpad.2020.69_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/gps.760","article-title":"Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia","volume":"17","author":"Serfaty","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.14283\/jpad.2020.69_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","article-title":"A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","volume":"26","author":"Singer","year":"2003","journal-title":"Sleep"},{"key":"10.14283\/jpad.2020.69_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2147\/CIA.S68557","article-title":"Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia living in long-term care facilities","volume":"9","author":"Figueiro","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.14283\/jpad.2020.69_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1994.tb01477.x","article-title":"Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia","volume":"89","author":"Mishima","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"10.14283\/jpad.2020.69_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2016.01.007","article-title":"Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease","volume":"40","author":"Liguori","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2020.69_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","article-title":"Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease","volume":"71","author":"Liguori","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2020.69_bib13","first-page":"70","article-title":"Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice","volume":"5","author":"Duncan","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2020.69_bib14","series-title":"Dayvigo (lemborexant) tablets [package insert]","year":"2019"},{"key":"10.14283\/jpad.2020.69_bib15","doi-asserted-by":"crossref","first-page":"e1918254","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.14283\/jpad.2020.69_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa123","article-title":"Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2","author":"Karppa","year":"2020","journal-title":"Sleep"},{"key":"10.14283\/jpad.2020.69_bib17","first-page":"189","article-title":"\u201cMini-mental state\u201d","volume":"12","author":"Folstein","year":"1975","journal-title":"A practical method for grading the cognitive state of patients for the clinician"},{"key":"10.14283\/jpad.2020.69_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.14283\/jpad.2020.69_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jagp.2012.10.027","article-title":"Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts","volume":"21","author":"Trzepacz","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.14283\/jpad.2020.69_bib20","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2013"},{"key":"10.14283\/jpad.2020.69_bib21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.14283\/jpad.2020.69_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-191124","article-title":"Sleep-wake cycle in Alzheimer's disease is associated with tau pathology and orexin dysregulation","volume":"74","author":"Liguori","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2020.69_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089198879100400405","article-title":"Sleep problems and institutionalization of the elderly","volume":"4","author":"Pollak","year":"1991","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.14283\/jpad.2020.69_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1532-5415.2005.53252.x","article-title":"Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial","volume":"53","author":"McCurry","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2020.69_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for Potentially Inappropriate Medication Use in Older Adults","volume":"67","author":"American Geriatrics Society 2019 Beers Criteria Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2020.69_bib26","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.14283\/jpad.2020.69_bib27","series-title":"Belsomra (suvorexant) tablets [package insert]","year":"2020"},{"key":"10.14283\/jpad.2020.69_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.smrv.2013.01.006","article-title":"Wrist actigraphy for measuring sleep in intervention studies with Alzheimer's disease patients: application, usefulness, and challenges","volume":"17","author":"Camargos","year":"2013","journal-title":"Sleep Med Rev"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:12:32Z","timestamp":1737321152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724003972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2274580724003972"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2020.69","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2020.69","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}